Zinger Key Points
- Novo Nordisk's shares declined following Viking Therapeutics' announcement of advancing its obesity drug VK2735 into late-stage trials.
- he options market for Novo Nordisk showed predominantly bearish sentiment, with 62% of recent trades being bearish.
- Our government trade tracker caught Pelosi’s 169% AI winner. Discover how to track all 535 Congress member stock trades today.
Novo Nordisk A/S Common Stock NVO experienced a notable decline on Thursday. This movement follows a significant announcement from competitor Viking Therapeutics Inc. VKTX.
What To Know: Viking Therapeutics announced the company has advanced its obesity candidate VK2735 into late-stage trials. This advancement has intensified competition in the GLP-1 market, which is currently led by Novo Nordisk and Eli Lilly corp. LLY.
Viking Therapeutics’ report of promising results for its obesity drug, showing up to a 15% reduction in body weight over 13 weeks, has pressured Novo Nordisk. This development challenges Novo Nordisk's leading position in the obesity treatment market.
What Else: The options market for Novo Nordisk has shown a predominantly bearish sentiment recently. Out of eight detected trades, 62% were bearish, including three put options totaling $155,555 and five call options amounting to $255,360.
Novo Nordisk’s trading volume reached 1,568,565, with the stock nearing oversold conditions according to RSI indicators. The company's next earnings report is expected in 13 days.
Analyst Opinions: Cantor Fitzgerald recently downgraded Novo Nordisk to ‘Overweight’ but maintained a price target of $160.
NVO Price Action: Novo Nordisk shares were down by 2.88% at $127.86 according to Benzinga Pro.

See Also:
Photo via Shutterstock.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.